Modern aspects of hepatology: liver steatosis and fibrosis through the prism of comorbidity in pediatric practice
Keywords:hepatic steatosis, hepatic fibrosis, non-alcoholic fatty liver disease, comorbid pathology, children and adolescents
The relevance of the topic is dictated by the growing prevalence of hepatic steatosis and fibrosis in the pediatric population, which is due to an increase in the number of pathologies of various organs and systems, which may be accompanied by the development of these liver lesions.
The aim of the study: to analyze the data of modern sources of scientific literature regarding the prevalence and features of the course of pathology of various organs and systems, which is associated with the development of steatosis and liver fibrosis in the pediatric population.
Materials and methods. A systematic search of scientific was carried out using Web of Science, Scopus, PubMed, scientific bases with key words: «hepatic steatosis», «hepatic fibrosis», «non-alcoholic fatty liver disease», «comorbid pathology», «children and adolescents».
Conclusions. Currently, the number of children and adolescents who are diagnosed with steatosis and/or fibrosis of the liver is increasing in the world. In particular, the formation of this pathology is associated with the presence of metabolic syndrome and is associated with its main components, such as obesity, hypertension, disorders of carbohydrate and lipid metabolism. More and more studies indicate the role of non-alcoholic fatty liver disease, which is based on steatosis, as a comorbid pathology in systemic, cardiovascular, endocrine diseases, gastrointestinal tract pathology, and genetic disorders. Also, a number of drugs with steatogenic and fibrogenic effects on liver tissue have been established, which are widely used in pediatric practice. It is necessary to monitor the structural and functional state of the liver already in childhood and adolescence for adequate treatment of the underlying disease and prevention of the formation of comorbid pathology
- Trefts, E., Gannon, M., Wasserman, D. H. (2017). The liver. Current Biology, 27 (21), R1147–R1151. doi: http://doi.org/10.1016/j.cub.2017.09.019
- Albanis, E., Friedman, S. L. (2001). Hepatic fibrosis. Pathogenesis and principles of therapy. Clinics in liver disease, 5 (2), 315–334. doi: http://doi.org/10.1016/s1089-3261(05)70168-9
- Bataller, R., Brenner, D. A. (2001). Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis. Seminars in Liver Disease, 21 (3), 437–452. doi: http://doi.org/10.1055/s-2001-17558
- Karanjia, R. N., Crossey, M. M. E., Cox, I. J., Fye, H. K. S., Njie, R., Goldin, R. D., Taylor-Robinson, S. D. (2016). Hepatic steatosis and fibrosis: Non-invasive assessment. World Journal of Gastroenterology, 22 (45), 9880–9897. doi: http://doi.org/10.3748/wjg.v22.i45.9880
- Alfani, R., Vassallo, E., De Anseris, A., Nazzaro, L., D’Acunzo, I., Porfito, C. et. al. (2018). Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. Children, 5 (12), 169. doi: http://doi.org/10.3390/children5120169
- Fang, Y.-L., Chen, H., Wang, C.-L., Liang, L. (2018). Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model.” World Journal of Gastroenterology, 24 (27), 2974–2983. doi: http://doi.org/10.3748/wjg.v24.i27.2974
- Anderson, E. L., Howe, L. D., Jones, H. E., Higgins, J. P. T., Lawlor, D. A., Fraser, A. (2015). The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLOS ONE, 10 (10), e0140908. doi: http://doi.org/10.1371/journal.pone.0140908
- Buznytska, O. V. (2014). Modern possibilities of non-invasive diagnosis of fibrosis at fatty liver disease in children and adolescents with obesity. Modern gastroenterology, 6, 19–24.
- Prokopowicz, Z., Malecka-Tendera, E., Matusik, P. (2018). Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology, 2018, 1–8. doi: http://doi.org/10.1155/2018/9465784
- Strashok, L. A., Buznytska, O. V., Meshkova, О. М. (2020). Indicators of lipid metabolism disorders in the blood serum of adolescents with metabolic syndrome. The Ukrainian Biochemical Journal, 92 (6), 137–142. doi: http://doi.org/10.15407/ubj92.06.137
- Pacifico, L., Bonci, E., Andreoli, G., Romaggioli, S., Di Miscio, R., Lombardo, C. V., Chiesa, C. (2014). Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutrition, Metabolism and Cardiovascular Diseases, 24 (7), 737–743. doi: http://doi.org/10.1016/j.numecd.2014.01.010
- Rutigliano, I., Vinci, R., De Filippo, G., Mancini, M., Stoppino, L., d’ Apolito, M. et. al. (2017). Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children. Nutrition, 36, 1–7. doi: http://doi.org/10.1016/j.nut.2016.10.017
- Daar, G., Serin, H. I., Ede, H., Husrevsahi, H. (2015). Association between the corrected QT interval, carotid artery intima-media thickness, and hepatic steatosis in obese children. The Anatolian Journal of Cardiology, 16 (7), 524–528. doi: http://doi.org/10.5152/anatoljcardiol.2015.6279
- Pacifico, L., Di Martino, M., De Merulis, A., Bezzi, M., Osborn, J. F., Catalano, C., Chiesa, C. (2013). Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology, 59 (2), 461–470. doi: http://doi.org/10.1002/hep.26610
- Cohen, M. E., Deepak, P., Khanna, G., Samson, C. M. (2020). Evaluation of Nonalcoholic Fatty Liver Disease in Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition, 72 (4), 574–578. doi: http://doi.org/10.1097/mpg.0000000000003023
- Pacifico, L., Martino, M. D., Anania, C., Andreoli, G. M., Bezzi, M., Catalano, C., Chiesa, C. (2015). Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease. World Journal of Gastroenterology, 21 (15), 4688–4695. doi: http://doi.org/10.3748/wjg.v21.i15.4688
- Bedogni, G., Gastaldelli, A., Manco, M., De Col, A., Agosti, F., Tiribelli, C., Sartorio, A. (2012). Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children. Nutrition, Metabolism and Cardiovascular Diseases, 22 (2), 120–126. doi: http://doi.org/10.1016/j.numecd.2010.05.003
- Xanthakos, S. A., Jenkins, T. M., Kleiner, D. E., Boyce, T. W., Mourya, R., Karns, R. et. al. (2015). High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. Gastroenterology, 149 (3), 623–634.e8. doi: http://doi.org/10.1053/j.gastro.2015.05.039
- Guo, Z., Li, M., Han, B., Qi, X. (2018). Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis. Digestive and Liver Disease, 50 (11), 1153–1162. doi: http://doi.org/10.1016/j.dld.2018.08.012
- Macut, D., Božić-Antić, I., Bjekić-Macut, J., Tziomalos, K. (2017). Management of endocrine disease: Polycystic ovary syndrome and nonalcoholic fatty liver disease. European Journal of Endocrinology, 177 (3), R145–R158. doi: http://doi.org/10.1530/eje-16-1063
- Ayonrinde, O. T., Adams, L. A., Doherty, D. A., Mori, T. A., Beilin, L. J., Oddy, W. H. et. al. (2016). Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. Journal of Gastroenterology and Hepatology, 31 (5), 980–987. doi: http://doi.org/10.1111/jgh.13241
- Carreau, A., Pyle, L., Garcia‐Reyes, Y., Rahat, H., Vigers, T., Jensen, T. et. al. (2019). Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS‐HS index). Clinical Endocrinology, 91 (4), 544–552. doi: http://doi.org/10.1111/cen.14062
- Mushannen, T., Cortez, P., Stanford, F. C., Singhal, V. (2019). Obesity and Hypogonadism – A Narrative Review Highlighting the Need for High-Quality Data in Adolescents. Children, 6 (5), 63. doi: http://doi.org/10.3390/children6050063
- Stancampiano, M. R., Lucas-Herald, A. K., Russo, G., Rogol, A. D., Ahmed, S. F. (2019). Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach. Hormone Research in Paediatrics, 92 (4), 215–228. doi: http://doi.org/10.1159/000504670
- Parkhomenko, L. K., Strashok, L. A., Turchyna, S. I., Yeloyeva, Z. V., Klymenko, T. M., Kosovtsova, H. V. et. al. (2021). Mechanisms of hepatic steatosis formation in adolescent boys with hypoandrogenism. Reproductive Endocrinology, 57, 79–83. doi: http://doi.org/10.18370/2309-4117.2021.57.79-83
- Chalasani, N., Amacher, D. (2014). Drug-Induced Hepatic Steatosis. Seminars in Liver Disease, 34 (2), 205–214. doi: http://doi.org/10.1055/s-0034-1375960
- Satapathy, S. K., Kuwajima, V., Nadelson, J., Atiq, O., Sanyal, A. J. (2015). Drug-induced fatty liver disease: An overview of pathogenesis and management. Annals of Hepatology, 14 (6), 789–806. doi: http://doi.org/10.5604/16652681.1171749
- Miele, L., Liguori, A., Marrone, G., Biolato, M., Araneo, C., Vaccaro, F. G. et. al. (2017). Fatty liver and drugs: the two sides of the same coin. European review for medical and pharmacological sciences, 21 (1 Suppl), 86–94.
- Goldmuntz, E. A., White, P. H. (2006). Juvenile Idiopathic Arthritis: A Review for the Pediatrician. Pediatrics in Review, 27 (4), e24–e32. doi: http://doi.org/10.1542/pir.27-4-e24
- Salliot, C., van der Heijde, D. (2008). Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Annals of the Rheumatic Diseases, 68 (7), 1100–1104. doi: http://doi.org/10.1136/ard.2008.093690
- Valentino, P. L., Church, P. C., Shah, P. S., Beyene, J., Griffiths, A. M., Feldman, B. M., Kamath, B. M. (2014). Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 20 (1), 47–59. doi: http://doi.org/10.1097/01.mib.0000436953.88522.3e
How to Cite
Copyright (c) 2021 Larysa Strashok, Svetlana Turchyna, Natalia Shevchenko, Zalina Yeloyeva, Olga Belousova, Olha Tsodikova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.